Form D · Pharmaceuticals

Afaxys, Inc.

Charleston, SC · CIK 0001503981

Offering snapshot reported Jul 14, 2025 · SEC filing

Reported sold
Yet to sell
Offering amount: $5M
Investors reported
0
Form D · investor count
Minimum accepted
$250K
Reported outside-investor minimum
First sale
Yet to occur
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jul 14, 2025InitialYet to sellNo comparison0SEC filing
Jun 28, 2023Initial$0No comparison0SEC filing
Jan 4, 2023InitialYet to sellNo comparison0SEC filing
Oct 21, 2010InitialYet to sellNo comparison0SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-551638

Source: Form D, filed Jul 14, 2025. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No matching detailed fund disclosure was found in the latest imported ADV filings. This does not establish that the issuer has no adviser.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Kirk Calhoun Director
Christine Charbonneau Director
Stacy Cross Director
Elizabeth Davila Director
Ronda K Dean Director, Executive
Natasha Giordano Director
Rod Markin Director
James Nash Director
Joan Neuscheler Director
Harold Oberkfell Director
Susan Overly Executive
Vince Russell Director
Sarah Stoesz Director
Bruce Williams Director
Linda Williams Director

Issuer details

Industry: Pharmaceuticals (See others in industry)

Address:
701 E. Bay Street Suite 402
Charleston, SC, 29403
Phone: 843-577-0703